MedTrace Logo

Hypervolemia in ESRD Patients in Zonguldak (Prospective Study)

NCT01468363 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 550

Last updated 2011-11-10

No results posted yet for this study

Summary

There is no easily applicable method to determine extra cellular volume and consequently estimate DW. Thus DW has to be clinically defined by ''trial and error'' and several indirect methods.

Recently, devices to measure DW by Bioimpedance spectroscopy (BİS) have become available. This non-invasive, cheap easily repeatable method has the potential to improve dialysis outcome in the majority of patients all over the world, The aim of the present project is to assess the feasibility of volume control by using a BİS device.

Conditions

  • Hemodialysis Fluid Allergy

Interventions

DEVICE

Dry weight adjustment

Dry weight adjustment according to BCM results

Sponsors & Collaborators

  • Zonguldak Bulent Ecevit University

    lead OTHER

Principal Investigators

  • Ender Hur, M.D · ZKU Nephrology Department

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01468363 on ClinicalTrials.gov